标题
Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 15, Pages -
出版商
Proceedings of the National Academy of Sciences
发表日期
2022-04-05
DOI
10.1073/pnas.2121098119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Does tissue imprinting restrict macrophage plasticity?
- (2021) Martin Guilliams et al. NATURE IMMUNOLOGY
- MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
- (2021) Yi Wang et al. Science Advances
- GSE4‐loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
- (2021) Laura Pintado‐Berninches et al. FASEB JOURNAL
- VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to sub-pleural pulmonary fibrosis
- (2021) Yu-Zhi Lu et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis
- (2021) Konstantin Tsoyi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury
- (2021) Stephen M. Niemiec et al. Nanomedicine-Nanotechnology Biology and Medicine
- Inhibition of aberrant tissue remodelling by mesenchymal stromal cells singly coated with soft gels presenting defined chemomechanical cues
- (2021) Sing Wan Wong et al. Nature Biomedical Engineering
- Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis
- (2021) Prathibha R. Gajjala et al. JCI Insight
- The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis
- (2021) Shan-shan Liu et al. IMMUNITY
- Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization
- (2020) Jie Wang et al. Cell Death & Disease
- Vascular Permeability in the Fibrotic Lung
- (2020) Clemens K. Probst et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
- (2020) Peter M George et al. Lancet Respiratory Medicine
- Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
- (2020) Fenghua Zhang et al. EMBO Molecular Medicine
- siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
- (2020) Wei Tao et al. Science Translational Medicine
- Protein-Based Nanoparticles as Drug Delivery Systems
- (2020) Seyoung Hong et al. Pharmaceutics
- Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis
- (2020) Ruyi Zou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Healing after Covid-19: Are Survivors at Risk for Development of Pulmonary Fibrosis?
- (2020) Lindsay T McDonald AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Fibrosis: from mechanisms to medicines
- (2020) Neil C. Henderson et al. NATURE
- Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis
- (2020) Elizabeth F. Redente et al. JCI Insight
- Machine Learning Analysis of the Bleomycin Mouse Model Reveals the Compartmental and Temporal Inflammatory Pulmonary Fingerprint
- (2020) Natalie Bordag et al. iScience
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
- (2019) Jiangsheng Xu et al. Nature Nanotechnology
- Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS–) vs. Alternatively Activated Macrophages
- (2019) Marco Orecchioni et al. Frontiers in Immunology
- Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
- (2019) Guorong Hu et al. Frontiers in Immunology
- A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signaling in monocyte-derived alveolar macrophages
- (2019) Nikita Joshi et al. EUROPEAN RESPIRATORY JOURNAL
- Deletion of c-FLIP from CD11bhi Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis
- (2018) Alexandra L. McCubbrey et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?
- (2018) Christopher J. Ryerson et al. EUROPEAN RESPIRATORY JOURNAL
- Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
- (2018) Pengfei Zhao et al. Chemical Science
- Nanomedicines for dysfunctional macrophage-associated diseases
- (2017) Hongliang He et al. JOURNAL OF CONTROLLED RELEASE
- Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
- (2017) Alexander V. Misharin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
- (2017) Ana L. Mora et al. NATURE REVIEWS DRUG DISCOVERY
- Immune Mechanisms in Pulmonary Fibrosis
- (2016) Saeed Kolahian et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues
- (2016) Yen-Rei A. Yu et al. PLoS One
- Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils
- (2014) Zhenjia Wang et al. Nature Nanotechnology
- Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
- (2013) Alexander V. Misharin et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease
- (2013) Marnix A Lameijer et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Ly6ChiMonocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
- (2011) Michael A. Gibbons et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Albumin-based nanoparticles as potential controlled release drug delivery systems
- (2011) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils
- (2009) Silvia M. Uriarte et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Inhibitors of clathrin-dependent endocytosis enhance TGF signaling and responses
- (2009) C.-L. Chen et al. JOURNAL OF CELL SCIENCE
- Pulmonary fibrosis: pathogenesis, etiology and regulation
- (2009) M S Wilson et al. Mucosal Immunology
- Murine models of pulmonary fibrosis
- (2007) Bethany B. Moore et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
- (2007) Antje Moeller et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started